Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure

Terapevticheskii Arkhiv

Volumn 78, Issue 5, 2006, Pages 45-50

  Kutyrina, I M ^a   Rudenko, T E ^a   Shvetsov, M Yu ^a   Kushnir, V V ^a  

^a NONE

Author keywords

Atherosclerosis; Cardiovascular complications; Chronic renal failure; Vascular remodeling

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HUMAN; LEG; MALE; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RISK FACTOR; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; KIDNEY FAILURE, CHRONIC; LOWER EXTREMITY; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 33745430749     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mailloux L.-U. Hypertension in chronic renal failure and ESRD: prevalence? Pathophysiology and outcomes. Semin. Nephrol. 2001; 21 (2): 146-156.
2. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol. Dial. Transplant. 2002; 17 (suppl. 11): 50-54.
3. London G. M., Marchais S. J., Guerin A. P. et al. Arterial structure and function in end-stage renal disease. Nephrol. Dial. Transplant. 2002; 17: 1713-1724.
4. Konings C., Dammers R., Rensma P. et al. Arterial wall properties in patients with chronic renal failure. Am. J. Kidney Dis. 2002; 39 (6): 1206-1212.
5. Cheung A. K., Sarnak M. J., Yan G. et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58: 353-362.
6. Shoji T., Emoto M., Tabata T. et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002; 61: 2187-2192.
7. Vanholder R., Massy Z., Argiles A. et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol. Dial. Transplant. 2005; 20: 1048-1056.
8. Guerin A. P., London G. M., Marchais S. J., Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol. Dial. Transplant. 2000; 15: 1014-1021.
9. Savage T., Clarke A., Giles M. Calcified plaques is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol. Dial. Transplant. 1998; 13: 2004-2012.
10. Cannata-Andia J. B., Rodriguez-Garcia M. Hyperphosphataemia as a cardiovascular risk factor - how to manage the problem. Nephrol. Dial. Transplant. 2002; 17 (suppl. 11): 16-19.
11. Chen N. X., O'Neill K. D., Duan D. et al. Phosphorus and uremic serum upregulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002; 62: 1724-1731.
12. Cozzolino M., Brancaccio D., Gallieni M., Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005; 68: 429-436.
13. Moe S. M., Duan D., Doehle A. et al. Uremia induces the osteoblast differentiation factor Cbfal in human blood vessels. Kidney Int. 2003; 63: 1003-1011.
14. London G. M., Guerin A. P., Marchais S. J. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 2003; 18: 1731-1740.
15. Blacher J., Guerin A., Pannier B. et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 103: 987-992.
16. Shinohara K., Shoji T., Tsujimoto Y. et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 2004; 65: 936-943.